GLPBio

Apoptosis

Read More about this category

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

 

References:

1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.

2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.

3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.

4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.

5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Research Areas

Products Related to Apoptosis(3359)

  • GN10456 structure
    GN10456L-Theanine
    CAS: 3081-61-6
    Purity: >99.50%

    L-Theanine is a natural non-protein amino acid with neuroprotective and anti-inflammatory effects.

  • GN10457 structure
    GN10457Oleuropein
    CAS: 32619-42-4
    Purity: >98.00%

    Oleuropein은 올리브 나무의 주요 페놀 화합물로 강력한 항산화 및 항염증 특성을 가지고 있다.

  • GN10462 structure
    GN10462Pulsatilla saponin D
    CAS: 68027-15-6
    Purity: >98.00%
  • GN10463 structure
    GN10463Chelerythrine
    CAS: 34316-15-9
    Purity: >98.00%
  • GN10470 structure
    GN10470Eriodictyol
    CAS: 552-58-9
    Purity: >99.50%
  • GN10484 structure
    GN10484Amentoflavone
    CAS: 1617-53-4
    Purity: >98.00%

    Amentoflavone is an orally active phenolic compound with anti-inflammatory, anti-oxidation, anti-microbial, and anti-cancer activities.

  • GN10491 structure
    GN10491Mangiferin
    CAS: 4773-96-0
    Purity: >99.50%
  • GN10503 structure
    GN10503Piceatannol
    CAS: 10083-24-6
    Purity: >98.00%

    Piceatannol(Piceatannol,3,3',4,5'-trans-trihydroxystilbene)은 레스베라트롤의 자연 발생하는 유사물이다.

  • GN10504 structure
    GN10504Echinocystic acid
    CAS: 510-30-5
    Purity: >98.00%
  • GN10506 structure
    GN10506Umbelliferone
    CAS: 93-35-6
    Purity: >99.50%
  • GN10507 structure
    GN10507Baohuoside I
    CAS: 113558-15-9
    Purity: >98.00%

    Baohuoside I는 Epimedium koreanum Nakai에서 분리된 플라보노이드로 CXCR4의 억제제로 작용하고 CXCR4의 표현을 억제하고 세포사멸을 유도하고 항종양 활동을 나타낸다.

  • GN10520 structure
    GN10520Benzoylpaeoniflorin
    CAS: 38642-49-8
    Purity: >98.00%
  • GN10521 structure
    GN10521Curcumol
    CAS: 4871-97-0
    Purity: >99.00%
  • GN10527 structure
    GN10527Formononetin
    CAS: 485-72-3
    Purity: >99.50%

    Formononetin은 효과적인 FGFR2 억제제로 IC 50 가 4.3μM이다. Formononetin은 혈관 형성과 종양 성장을 강력하게 억제한다.

  • GN10529 structure
    GN10529Demethoxycurcumin
    CAS: 22608-11-3;24939-17-1
    Purity: >99.00%
  • GN10531 structure
    GN10531Dimethylfraxetin
    CAS: 6035-49-0
    Purity: >99.50%
  • GN10534 structure
    GN10534Asiaticoside
    CAS: 16830-15-2
    Purity: >98.00%

    Asiaticoside는 센텔라 아시아티카에서 추출한 오리고리테르펜 사포시드이다.

  • GN10535 structure
    GN10535Cucurbitacin B
    CAS: 6199-67-3
    Purity: >98.00%

    Cucurbitacin B is a kind of tetracyclic triterpenoid compounds isolated from cucurbitaceae, and exhibits a wide range of biological activities.

  • GN10538 structure
    GN10538Ginsenoside Rh1
    CAS: 63223-86-9
    Purity: >98.00%
  • GN10539 structure
    GN10539Bergenin
    CAS: 477-90-7
    Purity: >99.50%
  • GN10543 structure
    GN10543caudatin
    CAS: 38395-02-7
    Purity: >98.00%
  • GN10544 structure
    GN10544Ginsenoside Rg1
    CAS: 22427-39-0
    Purity: >98.00%

    Ginsenoside Rg1은 인삼에서 발견된 주요 활성 성분 중 하나로 광범위한 생물학적 활동을 가진 자연 제품으로 알려진 스테로이드 글리코사이드류이다.

  • GN10547 structure
    GN10547β-Sitosterol
    CAS: 83-46-5
    Purity: >98.00%

    β-Sitosterol은 식물에서 유래된 자연 스테롤로 암 발병을 억제하는 등 다양한 생물학적 활성을 가지고 있다. β-Sitosterol은 또한 심혈관 건강에 미치는 영향을 연구하기 위해 일반적으로 사용된다.

  • GN10560 structure
    GN10560α-hederin
    CAS: 27013-91-8
    Purity: >98.00%